Last Update 03 Apr 26
RYAM: Accelerating Value Over Volume Repricing Will Support A More Constructive Outlook
Analysts have raised their price target on Rayonier Advanced Materials to $14 from $9, citing what they describe as a significant acceleration in the company's value-over-volume and repricing efforts, along with a market reaction they view as broadly aligned with that shift.
Analyst Commentary
Analysts highlighting the new US$14 price target frame it as a vote of confidence in Rayonier Advanced Materials' value-over-volume focus and pricing efforts, while also acknowledging execution and market risks that could affect how the story plays out.
Bullish Takeaways
- Bullish analysts point to the shift toward value over volume as a key driver for potential margin quality, arguing that prioritizing more profitable business over pure volume can support the new valuation target.
- The repricing efforts are seen as gaining traction, with analysts suggesting that clearer pricing discipline gives investors more confidence in the company’s ability to align its product mix with profitability goals.
- Messaging around recent results is viewed as more consistent and focused, which bullish analysts see as helpful for reducing uncertainty around execution and supporting a higher target price.
- The market reaction so far is viewed by bullish analysts as directionally in line with the value-over-volume narrative, which they see as an important confirmation that investors are starting to price in this shift.
Bearish Takeaways
- Bearish analysts remain cautious that a value-over-volume approach can take time to fully show up in financial results, which could create periods where the share price and fundamentals feel out of sync.
- There is concern that repricing efforts may face pushback from some customers, which could pressure volumes or create variability in revenue, even if the long term goal is better profitability.
- Some cautious analysts question whether the recent market response might already reflect a lot of optimism around execution, leaving less room for error if future updates are less supportive.
- Execution on both the value-over-volume and repricing plans requires consistent delivery, and bearish analysts highlight that any missteps could challenge the assumptions behind the higher target.
What's in the News
- Rayonier Advanced Materials has proposed an amendment to its Amended and Restated Certificate of Incorporation that would declassify the Board of Directors. This change would typically move directors to annual elections instead of staggered terms (Key Developments).
- The company reported that from September 28, 2025 to December 31, 2025, it repurchased 0 shares for US$0 million, and that it has completed the repurchase of 2,570,449 shares, representing 5.01% of shares for US$39.72 million under the buyback announced on February 20, 2018 (Key Developments).
- Effective January 5, 2026, Rayonier Advanced Materials appointed Scott M. Sutton as Chief Executive Officer, succeeding De Lyle W. Bloomquist as part of a previously announced leadership transition (Key Developments).
- Scott M. Sutton brings more than three decades of global leadership experience in chemicals and materials, including prior roles as President and CEO of Olin Corporation, Chief Operating Officer of Celanese Corporation, and leadership positions at Prince International Corporation, as well as current directorships at Celanese and OPAL Fuels Inc. (Key Developments).
Valuation Changes
- Fair Value: The $14.50 fair value estimate is unchanged, with the updated model keeping this headline valuation level steady.
- Discount Rate: The discount rate has risen slightly from 9.26% to 9.32%, a small adjustment that modestly lifts the required return used in the analysis.
- Revenue Growth: The revenue growth assumption is effectively unchanged at about 2.75%, indicating no material shift in top line expectations.
- Net Profit Margin: The net profit margin assumption remains essentially flat at about 12.61%, suggesting the profitability profile in the model is stable.
- Future P/E: The future P/E has risen slightly from 6.32x to 6.33x, a very small change that signals only a minimal tweak to the earnings multiple applied.
Key Takeaways
- Global demand for sustainable cellulose-based products and favorable trade policies are driving revenue and margin growth, with industry shifts benefiting North American producers.
- Strategic investments in automation, biomaterials, and cost efficiency are set to reduce production costs, diversify revenue, and improve long-term cash flow.
- Operational disruptions, market softness, cost inflation, and execution risks threaten margins, revenue stability, and the company's ability to successfully commercialize new initiatives and achieve financial targets.
Catalysts
About Rayonier Advanced Materials- Manufactures and sells cellulose specialty products in the United States, China, Europe, Japan, rest of Asia, Canada, Latin America, and internationally.
- The stabilization of trade policies and resolution of tariff uncertainties, especially in China and the US, are reversing previous export disruptions; this is anticipated to drive a rebound in cellulose specialties volumes and improved pricing, supporting topline revenue growth and enhanced EBITDA margins going forward.
- Accelerated growth in global demand for cellulose-based products-driven by consumer and corporate shifts toward sustainable, bio-based materials and tightening climate policy-is expanding addressable markets for Rayonier Advanced Materials; this underpins expectations for both revenue and margin expansion as specialty cellulose gains share across diverse end markets.
- Strategic investments in process automation, operational efficiencies, and cost reduction-already underway-are expected to lower unit production costs meaningfully by 2026, setting the stage for sustainable improvements in net margins and cash flow conversion.
- Successful execution of high-return biomaterial projects (bioethanol, biofuels, tall oil) leveraging existing infrastructure is projected to add significant incremental EBITDA (with equity returns of 7x–10x on capital invested), further diversifying the company's revenue base and meaningfully increasing long-term free cash flow.
- Industry consolidation, heightened supply chain localization, and a strong balance sheet position Rayonier Advanced Materials to capture market share from exiting or disadvantaged competitors, particularly as environmental regulations and tariffs provide tailwinds to North American producers; this dynamic is set to support higher capacity utilization rates and stronger pricing power, positively impacting both revenue and margins.
Rayonier Advanced Materials Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Rayonier Advanced Materials's revenue will grow by 2.7% annually over the next 3 years.
- Analysts assume that profit margins will increase from -29.0% today to 12.6% in 3 years time.
- Analysts expect earnings to reach $200.6 million (and earnings per share of $3.0) by about April 2029, up from -$425.2 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 6.4x on those 2029 earnings, up from -1.7x today. This future PE is lower than the current PE for the US Chemicals industry at 29.2x.
- Analysts expect the number of shares outstanding to grow by 0.35% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.32%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Despite management's assertion that 2025 headwinds are largely "onetime," recurring operational disruptions-including labor strikes, outages, and production challenges-have been a consistent feature and may reflect deeper structural issues with the company's aging asset base and manufacturing processes, posing ongoing risks to future production volumes and EBITDA margins.
- Persistent softness in the paperboard and high-yield pulp segments, as well as ongoing exposure to volatile global pulp pricing and oversupply conditions (especially in China), could continue to weigh on overall revenues and segment-level profitability, undermining full recovery and target margin expansion.
- The company's ambitious biomaterials initiatives and capital deployment plans rely heavily on successful execution of new projects and commercialization in established but highly competitive markets; failure to meet commercialization timelines or secure favorable offtake agreements could delay or reduce projected earnings and free cash flow, especially if market entrants intensify competition or prices soften.
- RYAM's high reliance on a few core segments and customers, and the plan to divest noncore assets for deleveraging, could expose the company to revenue volatility and increase financial risk if divestitures fetch lower-than-expected valuations or if execution is delayed, ultimately straining net leverage targets and future capital flexibility.
- Ongoing inflation in wage, energy, and raw materials costs, combined with the need for continued capital expenditures on process automation and facility upgrades, may structurally compress margins and free cash flow, especially if input cost increases outpace gains from efficiency initiatives or if industry pricing power abates.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $14.5 for Rayonier Advanced Materials based on their expectations of its future earnings growth, profit margins and other risk factors.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.6 billion, earnings will come to $200.6 million, and it would be trading on a PE ratio of 6.4x, assuming you use a discount rate of 9.3%.
- Given the current share price of $10.62, the analyst price target of $14.5 is 26.8% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Rayonier Advanced Materials?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.


